KEROS THERAPEUTICS INC's ticker is KROS and the CUSIP is 492327101. A total of 123 filers reported holding KEROS THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.04 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $4,773,488 | -66.0% | 149,733 | -57.2% | 0.01% | -66.7% |
Q2 2023 | $14,049,339 | +60.0% | 349,660 | +70.0% | 0.04% | +55.6% |
Q1 2023 | $8,781,682 | -64.9% | 205,660 | -60.5% | 0.03% | -68.2% |
Q4 2022 | $24,996,139 | +623.5% | 520,536 | +466.8% | 0.08% | +507.1% |
Q3 2022 | $3,455,000 | -6.3% | 91,840 | +45.7% | 0.01% | -6.7% |
Q4 2021 | $3,688,000 | -37.3% | 63,028 | -57.6% | 0.02% | -42.3% |
Q3 2021 | $5,879,000 | -65.6% | 148,600 | -63.1% | 0.03% | -66.2% |
Q2 2021 | $17,099,000 | +24.5% | 402,607 | +80.4% | 0.08% | +20.3% |
Q1 2021 | $13,736,000 | -8.9% | 223,162 | +4.4% | 0.06% | -13.5% |
Q4 2020 | $15,081,000 | +384.0% | 213,800 | +164.6% | 0.07% | +362.5% |
Q3 2020 | $3,116,000 | -45.5% | 80,800 | -46.9% | 0.02% | -56.8% |
Q2 2020 | $5,713,000 | – | 152,300 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management IV, LLC | 1,412,705 | $99,652,000 | 10.82% |
CHI Advisors LLC | 433,852 | $30,604,000 | 8.62% |
VR Adviser, LLC | 672,306 | $47,424,000 | 6.97% |
Consonance Capital Management LP | 557,095 | $39,297,000 | 3.67% |
Logos Global Management LP | 450,000 | $31,743,000 | 2.72% |
RA Capital Management | 1,875,000 | $132,263,000 | 1.85% |
Nantahala Capital Management | 534,514 | $37,705,000 | 1.17% |
Orbimed Advisors | 1,679,417 | $118,466,000 | 1.04% |
Eventide Asset Management | 346,000 | $24,407,000 | 0.37% |
Atom Investors LP | 49,981 | $3,526,000 | 0.36% |